Literature DB >> 17686387

Clinical use of opioids for cancer pain.

Dermot R Fitzgibbon1.   

Abstract

Successful management of pain in the cancer patient requires careful assessment of the components of the pain complaint and accurate diagnosis of the cause of pain. Symptomatic management of pain involves pharmacotherapeutic strategies that focus on opioid use. Factors influencing the choice of opioid in patients with cancer pain include the severity of pain, the presence of coexisting disease, response to previous analgesic therapy, pharmacokinetic factors, available formulations, and patient compliance. Long-term opioid prescription always requires individual titration of medication to adequate pain relief, which is determined on an individual patient basis and/or based on manageable adverse effects. Failure to continuously monitor opioid use generally results in overtreatment or undertreatment of pain. The cognitive and psychomotor effects of long-term opioid therapy are not well-defined and merit further study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17686387     DOI: 10.1007/s11916-007-0200-x

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  46 in total

Review 1.  Strategies for the treatment of cancer pain in the new millennium.

Authors:  C Ripamonti; E D Dickerson
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Oral patient-controlled analgesia.

Authors:  P H Coluzzi
Journal:  Semin Oncol       Date:  1997-10       Impact factor: 4.929

3.  Effects of intermediate- and long-term use of opioids on cognition in patients with chronic pain.

Authors:  Stanley L Chapman; Michael G Byas-Smith; Barbara A Reed
Journal:  Clin J Pain       Date:  2002 Jul-Aug       Impact factor: 3.442

Review 4.  The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses.

Authors:  G R Uhl; I Sora; Z Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

5.  Practice guidelines for cancer pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management, Cancer Pain Section.

Authors: 
Journal:  Anesthesiology       Date:  1996-05       Impact factor: 7.892

6.  No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients.

Authors:  Julia Riley; Joy R Ross; Dag Rutter; Athol U Wells; Katherine Goller; Ron du Bois; Ken Welsh
Journal:  Support Care Cancer       Date:  2005-06-11       Impact factor: 3.603

7.  Driving ability in cancer patients receiving long-term morphine analgesia.

Authors:  A Vainio; J Ollila; E Matikainen; P Rosenberg; E Kalso
Journal:  Lancet       Date:  1995-09-09       Impact factor: 79.321

8.  Management of cancer pain guideline overview. Agency for Health Care Policy and Research Rockville, Maryland.

Authors: 
Journal:  J Natl Med Assoc       Date:  1994-08       Impact factor: 1.798

Review 9.  Cytochrome P450 2D6 metabolism and 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting.

Authors:  Piotr K Janicki
Journal:  Med Sci Monit       Date:  2005-09-26

10.  Effects of opioids on driving ability.

Authors:  T Galski; J B Williams; H T Ehle
Journal:  J Pain Symptom Manage       Date:  2000-03       Impact factor: 3.612

View more
  1 in total

Review 1.  Cognitive effects of opioids.

Authors:  Scott A Strassels
Journal:  Curr Pain Headache Rep       Date:  2008-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.